☆Caligan Partners LP
Quality Q
0.722
AUM ($M)
2,073
Positions
25
Turnover
0.25
Top-10 wt
83%
Herfindahl
0.151
History (qtrs)
6
Excess Return
—
AI Eval Run AI Eval
Holdings · 29 positions · portfolio value $2,073M
| Ticker | Name | Activity | Security Type | Weight | Δ Weight | Value ($M) | Shares | Δ Shares | Qtrs Held | Excess Return |
|---|---|---|---|---|---|---|---|---|---|---|
| ☆LQDA funds › | LIQUIDIA CORPORATION | HOLD | — | 31.2% | +9.6% | 647.3 | 8,118,892 | +0 | 5 | — |
| ☆RVMD funds › | REVOLUTION MEDICINES INC | ADD | — | 17.7% | +6.4% | 367.4 | 1,961,795 | +308,987 | 5 | — |
| ☆ABVX funds › | ABIVAX SA | ADD | — | 10.0% | -1.5% | 207.6 | 1,557,924 | +96,000 | 5 | — |
| ☆PCVX funds › | VAXCYTE INC | ADD | — | 6.1% | -2.3% | 127.2 | 2,188,636 | +127,917 | 3 | — |
| ☆EXEL funds › | EXELIXIS INC | HOLD | — | 4.1% | -0.6% | 84.5 | 1,553,262 | +0 | 5 | — |
| ☆TNGX funds › | TANGO THERAPEUTICS INC | ADD | — | 3.8% | +0.2% | 78.2 | 2,500,103 | +91,305 | 3 | — |
| ☆AVTX funds › | AVALO THERAPEUTICS INC | ADD | — | 2.8% | +1.1% | 58.5 | 3,163,866 | +1,528,843 | 4 | — |
| ☆XENE funds › | XENON PHARMACEUTICALS INC | TRIM | — | 2.6% | -3.1% | 53.7 | 889,944 | -503,083 | 4 | — |
| ☆ADMA funds › | ADMA BIOLOGICS INC | ADD | Common Stock | 2.3% | -0.7% | 47.9 | 5,725,007 | +968,496 | 4 | — |
| ☆LBRX funds › | LB PHARMACEUTICALS INC | HOLD | — | 2.3% | -0.2% | 46.7 | 1,438,070 | +0 | 2 | — |
| ☆IMCR funds › | IMMUNOCORE HLDGS PLC | NEW | — | 2.1% | +2.1% | 43.9 | 1,381,317 | +1,381,317 | 1 | — |
| ☆VRDN funds › | VIRIDIAN THERAPEUTICS INC | NEW | — | 1.9% | +1.9% | 40.3 | 2,193,981 | +2,193,981 | 1 | — |
| ☆VOR funds › | VOR BIOPHARMA INC | HOLD | — | 1.7% | -0.7% | 35.4 | 1,925,066 | +0 | 3 | — |
| ☆SABS funds › | SAB BIOTHERAPEUTICS INC | HOLD | — | 1.5% | -0.7% | 31.1 | 7,967,207 | +0 | 2 | — |
| ☆IVA funds › | INVENTIVA SA | ADD | — | 1.5% | -0.5% | 30.9 | 8,163,191 | +3,188,285 | 3 | — |
| ☆AURA funds › | AURA BIOSCIENCES INC | ADD | — | 1.5% | +1.4% | 30.5 | 4,298,248 | +4,068,384 | 2 | — |
| ☆TYRA funds › | TYRA BIOSCIENCES INC | TRIM | — | 1.2% | -2.2% | 25.8 | 806,986 | -469,982 | 5 | — |
| ☆IRD funds › | OPUS GENETICS INC | ADD | — | 1.2% | -0.8% | 25.0 | 6,077,084 | +2,056 | 2 | — |
| ☆ANIK funds › | ANIKA THERAPEUTICS INC | HOLD | — | 1.0% | -0.5% | 21.0 | 1,435,130 | +0 | 5 | — |
| ☆SGMT funds › | SAGIMET BIOSCIENCES INC | NEW | — | 0.9% | +0.9% | 19.3 | 2,500,000 | +2,500,000 | 1 | — |
| ☆ARTV funds › | ARTIVA BIOTHERAPEUTICS INC | NEW | — | 0.8% | +0.8% | 16.8 | 1,736,111 | +1,736,111 | 1 | — |
| ☆FTH funds › | FAETH THERAPEUTICS INC | ADD | — | 0.8% | +0.5% | 15.7 | 629,467 | +503,465 | 2 | — |
| ☆MBX funds › | MBX BIOSCIENCES INC | TRIM | — | 0.5% | -1.3% | 11.0 | 200,000 | -648,590 | 2 | — |
| ☆VRCA funds › | VERRICA PHARMACEUTICALS INC | HOLD | — | 0.3% | -0.1% | 5.7 | 923,910 | +0 | 4 | — |
| ☆CLRB funds › | CELLECTAR BIOSCIENCES INC | NEW | — | 0.1% | +0.1% | 1.3 | 469,998 | +469,998 | 1 | — |
| ☆MAZE funds › | MAZE THERAPEUTICS INC | EXIT | — | 0.0% | -1.3% | 0.0 | 0 | -614,962 | 0 | — |
| ☆XLO funds › | XILIO THERAPEUTICS INC | EXIT | — | 0.0% | -0.1% | 0.0 | 0 | -112,128 | 0 | — |
| ☆MLYS funds › | MINERALYS THERAPEUTICS INC | EXIT | — | 0.0% | -5.3% | 0.0 | 0 | -2,772,654 | 0 | — |
| ☆SYRE funds › | SPYRE THERAPEUTICS INC | EXIT | — | 0.0% | -3.1% | 0.0 | 0 | -878,127 | 0 | — |
Point-in-time history
| Period | AUM ($M) | Positions | Turnover | Top-10 wt | Herfindahl | Quality Q | Skill | Universe |
|---|---|---|---|---|---|---|---|---|
| 2026Q2 | 2,073 | 25 | 0.25 | 83% | 0.151 | 0.720 | — | in |
| 2026Q1 | 1,414 | 24 | 0.24 | 79% | 0.096 | 0.677 | — | in |
| 2025Q4 | 1,092 | 20 | 0.22 | 88% | 0.131 | 0.702 | — | in |
| 2025Q3 | 721 | 16 | 0.44 | 93% | 0.139 | 0.259 | — | in |
| 2025Q2 | 515 | 16 | 0.19 | 94% | 0.145 | 0.748 | — | entered |
| 2025Q1 | 479 | 16 | 0.00 | 92% | 0.134 | 0.000 | — | out |
Long US-equity 13F disclosures only · up to 45-day reporting lag · sells = reduce/avoid, not short.
JSON: /api/signals ·
/api/funds ·
/api/status